Blood Eosinophilia is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA

• Auteurs principaux: Alvaro Moreira (Auteur), Michael Erdmann (Auteur), Ugur Uslu (Auteur), Verona Vass (Auteur), Gerold Schuler (Auteur), Beatrice Schuler-Thurner (Auteur)
• Format: Livre
• Publié: MDPI AG, 2020-03-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: The approvals of immune checkpoint inhibitors for several cancer types and the rapidly growing recognition that T cell-based immunotherapy significantly improves outcomes for cancer patients led to a re-emergence of cancer vaccines, including dendritic cell (DC)-based immunotherapy. Bloo...